Clinical Trial Update: HLADQA1*05 Genotype and the Efficacy of Treatment With Infliximab in Chinese Population Crohn's Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating the impact of HLADQA1*05 genotype on the efficacy of infliximab in Chinese patients with Crohn's disease; status is not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Crohn Disease, Infliximab | Phase 4 | Status: NOT_YET_RECRUITING